BACKGROUND: We examined the molecular epidemiology of tuberculosis (TB) in San Francisco during a 13-year period encompassing the peak of TB resurgence and subsequent decline to historic low levels. OBJECTIVE: To compare rates of TB caused either by rapid progression of recent Mycobacterium tuberculosis infection or by reactivation of latent infection. METHODS: All TB cases reported from 1991 to 2003 were included. Genotyping was performed to identify clustered cases. RESULTS: The annual TB case rate decreased significantly from 50.8 to 28.8 cases/100000 persons from 1992 to 1999 (P < 0.0001). After 1999, no significant decrease was observed for the population as a whole or in any subgroup examined. Similarly, the rate of clustered cases decreased significantly from 1992 to 1999 (11.4 to 3.1 cases/100000, P < 0.0001). Although the rate of non-clustered cases also declined significantly (25.6 to 17.6 cases/100,000, P < 0.0001), there was a disproportionate reduction in clustered cases (94.7% vs. 50.8%, P < 0.0001). Neither clustered nor non-clustered cases decreased significantly after 1999. CONCLUSIONS: TB case rates reached a plateau despite ongoing application of control measures implemented in 1993. These data suggest that intensification of measures designed to identify and treat persons with latent TB infection will be necessary to further reduce TB incidence.
BACKGROUND: We examined the molecular epidemiology of tuberculosis (TB) in San Francisco during a 13-year period encompassing the peak of TB resurgence and subsequent decline to historic low levels. OBJECTIVE: To compare rates of TB caused either by rapid progression of recent Mycobacterium tuberculosis infection or by reactivation of latent infection. METHODS: All TB cases reported from 1991 to 2003 were included. Genotyping was performed to identify clustered cases. RESULTS: The annual TB case rate decreased significantly from 50.8 to 28.8 cases/100000 persons from 1992 to 1999 (P < 0.0001). After 1999, no significant decrease was observed for the population as a whole or in any subgroup examined. Similarly, the rate of clustered cases decreased significantly from 1992 to 1999 (11.4 to 3.1 cases/100000, P < 0.0001). Although the rate of non-clustered cases also declined significantly (25.6 to 17.6 cases/100,000, P < 0.0001), there was a disproportionate reduction in clustered cases (94.7% vs. 50.8%, P < 0.0001). Neither clustered nor non-clustered cases decreased significantly after 1999. CONCLUSIONS: TB case rates reached a plateau despite ongoing application of control measures implemented in 1993. These data suggest that intensification of measures designed to identify and treat persons with latent TB infection will be necessary to further reduce TB incidence.
Authors: María Alonso; Marta Herranz; Miguel Martínez Lirola; Milagros González-Rivera; Emilio Bouza; Darío García de Viedma Journal: J Clin Microbiol Date: 2012-02-29 Impact factor: 5.948
Authors: Midori Kato-Maeda; Crystal A Shanley; David Ackart; Leah G Jarlsberg; Shaobin Shang; Andres Obregon-Henao; Marisabel Harton; Randall J Basaraba; Marcela Henao-Tamayo; Joyce C Barrozo; Jordan Rose; L Masae Kawamura; Mireia Coscolla; Viacheslav Y Fofanov; Heather Koshinsky; Sebastien Gagneux; Philip C Hopewell; Diane J Ordway; Ian M Orme Journal: Clin Vaccine Immunol Date: 2012-06-20
Authors: Gompol Suwanpimolkul; Leah G Jarlsberg; Jennifer A Grinsdale; Dennis Osmond; L Masae Kawamura; Philip C Hopewell; Midori Kato-Maeda Journal: Am J Respir Crit Care Med Date: 2013-05-01 Impact factor: 21.405
Authors: Adithya Cattamanchi; Raymund B Dantes; John Z Metcalfe; Leah G Jarlsberg; Jennifer Grinsdale; L Masae Kawamura; Dennis Osmond; Philip C Hopewell; Payam Nahid Journal: Clin Infect Dis Date: 2009-01-15 Impact factor: 9.079
Authors: Noelia Alonso-Rodriguez; Miguel Martínez-Lirola; M Luisa Sánchez; Marta Herranz; Teresa Peñafiel; Magdalena del Carmen Bonillo; Milagros Gonzalez-Rivera; Juan Martínez; Teresa Cabezas; Luis Felipe Diez-García; Emilio Bouza; Darío García de Viedma Journal: J Clin Microbiol Date: 2009-05-20 Impact factor: 5.948
Authors: Gerard de Vries; Rob A H van Hest; Conny C A Burdo; Dick van Soolingen; Jan H Richardus Journal: BMC Infect Dis Date: 2009-09-08 Impact factor: 3.090